Trek Financial’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Trek Financial’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.72M	Buy	+46,386	New	+$5.76M	0.26%	103

Other funds holding PJP

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return

Outlook Wealth Advisors Shenandoah, Texas $470M AUM 20.06% 1-Year Est. Return

Dumont & Blake Investment Advisors Princeton, New Jersey $398M AUM 22.72% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return

Capital Investment Advisory Services Raleigh, North Carolina $1.61B AUM 16.94% 1-Year Est. Return

Trek Financial's PJP Position: Q3 2026 in Review

Trek Financial opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q3 2026: 46,386 shares worth $5.72M. The stake represents 0.26% of the portfolio and ranks #103 among its holdings.

37 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

Trek Financial held 46,386 shares of Invesco Pharmaceuticals ETF worth $5.72M as of Q3 2026.
Invesco Pharmaceuticals ETF was a new Trek Financial position in Q3 2026.
Invesco Pharmaceuticals ETF made up 0.26% of Trek Financial's portfolio in Q3 2026, its #103 holding.
37 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Trek Financial's 13F filing for Q3 2026, filed 29 Oct 2026.